IFLNDNCT06694116
Charcoal Carbon Black Dye Use in Sentinel Lymph Node Mapping in Early Stage Vulvar Cancer
At risk: Primary completion moved at least 3 years later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Nov 2026 to Dec 2029 Show 5 more changesShow less
- Enrollment reopened
- Eligibility criteria revised
- Study completion pushed from Nov 2026 to Mar 2030
- Site details revised
- Publications: details revised at 5 of 5 entries
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Detection rate of sentinel lymph node(s)
Timeframe: Two years
Sensitivity of sentinel lymph node mapping
Timeframe: Two years
Specifity of sentinel lymph node mapping
Timeframe: Two years
Negative and positive predictive values
Timeframe: Two years
Arms and interventions
Single arm study using carbon dye as a sentinel lymph node agent in early vulvar cancerExperimental
Single arm study using carbon dye as a sentinel lymph node agent in early vulvar cancer. Sterile charcoal carbon dye will be injected around vulvar tumor which will be searched in IFLND. No other arms.
Diagnostic tests: sentinel lymph node biopsy using carbon dye
Sites
1 site in 1 country
- Istanbul University Med Fac Dept. of Obstet and Gynecol. Division of Gynecologic OncologyIstanbul, Turkey (Türkiye)